Browse Hierarchy CANM135: Molecular Targeted Therapies and Immunotherapy for Blood Cancers

Back to MD-CANC-CANC: Barts Cancer Institute
This module will cover the fundamental molecular and biological mechanisms involved in the development of leukaemia and lymphoma. It will specifically address the impact of chromosome abnormalities on the diagnosis, prognosis, risk stratification and management of patients, and include a theoretical and practical understanding of cytogenetic and molecular cytogenetic technology. The contribution of the host microenvironment to tumour cell survival and proliferation will also be discussed.

Sorry, there are no lists here yet. You could try:

  • Clicking My Lists from the menu. Your course enrolled lists are stored here.
  • Searching for the list using the form below:

Lists linked to Molecular Targeted Therapies and Immunotherapy for Blood Cancers

There are currently no lists linked to this Module.